Condition · ICD-10 N40.1

Benign Prostatic Hyperplasia

BPH / Enlarged Prostate

A non-cancerous enlargement of the prostate gland common in older men, causing urinary symptoms such as weak stream and frequent urination.

BPH affects over 50% of men over age 60 and over 80% by age 80. Urinary obstruction symptoms range from mild to severe. Alpha-blockers (tamsulosin, alfuzosin) provide rapid symptom relief; 5-alpha reductase inhibitors (finasteride, dutasteride) reduce prostate volume over months. Combination therapy is used for larger glands or more severe symptoms.

At a glance
Medications tracked
6
First-line options
Tamsulosin, Alfuzosin, Finasteride
Related conditions
ProstatitisUrinary Tract InfectionProstate CancerOveractive Bladder

First-line Related Treatments

Commonly associated primary options — verify with your clinician

Primary options
Tamsulosin
Tamsulosin
Rx
Capsule
Strength 0.4 mg
NDC 0228-3404-11
Alfuzosin
Alfuzosin
Rx
Tablet
Strength 10 mg
NDC 0024-5780-30
Finasteride
Finasteride
Rx
Tablet
Strength 5 mg
NDC 0093-7244-56

Short-term / As-needed

Related options for acute or bridging use

Acute or bridging use
Dutasteride
Dutasteride
Rx
Capsule
Strength 0.5 mg
NDC 0173-0718-04

Situational

Related options for specific presentations

Specific presentations
Doxazosin
Doxazosin
Rx
Tablet
Strength 4 mg
NDC 0069-4550-30
Terazosin
Terazosin
Rx
Capsule
Strength 5 mg
NDC 0074-3373-13

Top treatments tried for Benign Prostatic Hyperplasia

Community-driven data · early preview

Tamsulosin
1,800 people tried
4.3
Alfuzosin
1,520 people tried
4.1
Finasteride
1,240 people tried
4.0
Dutasteride
960 people tried
3.8
Help build the dataset — log treatments you've tried, rate what helped, and report side effects.